 |
For all your Quality Management and Continual Improvement Initiatives and Standards
|
| View previous topic :: View next topic |
| Author |
Message |
GaryW Site Admin

Joined: 14 Oct 2005 Posts: 83186 Location: Adelaide, Australia

|
Posted: Sat Mar 13, 2010 7:48 am Post subject: Newly-Published Study Reinforces Role Of Antiepileptic Drug Vimpat(R) (lacosamide) (C-V) As An Add-on Treatment That Significantly Reduces Epilepsy |
|
|
UCB announced that the antiepileptic drug (AED) Vimpat® (lacosamide) (C-V) demonstrated significantly fewer partial-onset seizures versus placebo in adults living with epilepsy, according to a Phase III clinical study published online in Epilepsia. This study was one of three that supported the approval of Vimpat by the U.S...
Read more...
Source: Pharma Industry / Biotech Industry News From Medical News Today
Latest Health News and Medical News posted throughout the day, every day. _________________ Regards,
Gary Wilkinson
Founder & Principal Consultant
SQR Consulting |
|
| Back to top |
|
 |
|
|
You cannot post new topics in this forum You cannot reply to topics in this forum You cannot edit your posts in this forum You cannot delete your posts in this forum You cannot vote in polls in this forum You cannot attach files in this forum You cannot download files in this forum
|
|
|
© 2005 SQR Consulting - All rights reserved
ABN : 60512166070
Powered by phpBB © 2001, 2005 phpBB Group
|